Doctor profile · Federal record
Dr. Michael Bagley, MD
Dermatology Physician (CMS: Dermatology) · Warren, NJ
- NPI 1790703486
- Accepts Medicare
- MIPS 84.7 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
122 Mt Bethel RD Ste 1, Warren Dermatology Assoc LLC
Warren, NJ 07059
(908) 756-7999
fax (908) 756-8017 - Mailing address
-
2 Ingram Circle
Aberdeen, NJ 07747
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- February 13, 2013
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New Jersey #25MA04581000
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1790703486. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,035
Distinct HCPCS
10
Medicare allowed
$72,209
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 302 | 244 | $100 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 265 | 66 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 142 | 111 | $67 | |
11102 |
Biopsy of related skin growth, first growth | 112 | 100 | $114 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 110 | 102 | $63 | |
17110 |
Destruction of skin growth, 1-14 growths | 28 | 27 | $132 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 26 | 26 | $124 | |
11103 |
Biopsy of related skin growth, each additional growth | 20 | 17 | $58 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 19 | 19 | $81 | |
69100 |
Biopsy of ear | 11 | 11 | $106 |
In context: peer comparison
Among 1 peers in Warren Dermatology Physician, average services per provider: 103. This provider delivers 10× the peer median.Open Payments
Industry payments received
All-time total
$1,038
Transactions
68
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 15 | $184.59 | |
| Amgen INC. | 10 | $152.51 | |
| Dermavant Sciences, INC. | 11 | $151.61 | |
| Leo Pharma INC. | 4 | $69.70 | |
| Lilly USA, LLC | 4 | $64.24 | |
| Novartis Pharmaceuticals Corporation | 3 | $52.05 | |
| Galderma Laboratories, L.P. | 3 | $50.26 | |
| Ucb, INC. | 3 | $46.73 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $45.74 | |
| Arcutis Biotherapeutics, INC. | 2 | $38.09 | |
| Celgene Corporation | 2 | $36.47 | |
| Mayne Pharma Commercial LLC | 3 | $35.74 | |
| Pfizer INC. | 2 | $32.03 | |
| Janssen Biotech, INC. | 2 | $30.76 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $16.55 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
279
Patients
179
Total drug cost
$46,616
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 55 | 35 | $620 |
| Ketoconazole | Generic | 53 | 33 | $1,017 |
| Hydrocortisone | Generic | 43 | 34 | $246 |
| Clobetasol Propionate | Generic | 32 | 20 | $866 |
| Fluorouracil | Generic | 31 | 29 | $1,856 |
| Fluocinonide | Generic | 26 | 16 | $1,365 |
| Calcipotriene | Generic | 16 | 0 | $2,330 |
| Amoxicillin | Generic | 12 | 12 | $43 |
| Dupixent Pen (Dupilumab) | Brand | 11 | 0 | $38,273 |
Frequently asked questions
What is Dr. Michael Bagley's medical specialty?
Dr. Michael Bagley practices Dermatology Physician in Warren, NJ.
Where does Dr. Michael Bagley practice?
Dr. Michael Bagley practices at 122 Mt Bethel RD Ste 1, Warren, NJ 07059. Office phone: 9087567999.
What is Dr. Michael Bagley's NPI?
Dr. Michael Bagley's National Provider Identifier (NPI) is 1790703486, issued by NPPES.
Does Dr. Michael Bagley accept Medicare assignment?
Yes. Dr. Michael Bagley accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Bagley commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.